Toxoplasma gondii infection is widespread worldwide, not only posing a serious threat to human food safety and animal husbandry, but also endangering human health. The selectivity index was employed to measure anti-T. gondii activity. Hederagenin (HE) exhibited potent anti-T. gondii activity and low cytotoxicity. For this reason, HE was selected for in vivo experiments. HE showed 64.8%±13.1% inhibition for peritoneal tachyzoites in mice, higher than spiramycin 56.8%±6.0%. Biochemical parameters such as alanine aminotransferase, aspartate aminotransferase, glutathione, and malondialdehyde, illustrated that HE was a good inhibitor of T. gondii in vivo. This compound was also effective in relieving T. gondii-induced liver damage. Collectively, it was demonstrated that HE had potential as an anti-T. gondii agent.
Citations
Citations to this article as recorded by
Daflon illuminates a novel avenue in treating acute toxoplasmosis: An experimental study Nahla El Skhawy, Aceel Y. Hassan, Sarah Ahmed Hassan, Hala E. Diab Veterinary Parasitology.2026; 345: 110788. CrossRef
An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives Huize Zhang, Yong Li, Yi Liu Frontiers in Pharmacology.2024;[Epub] CrossRef
Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives Siyang Liu, Minghao Cai, Zhendi Liu, Weixin Gao, Junjie Li, Yuxueqing Li, Xiayire Abudouxukuer, Jili Zhang Journal of Medicinal Chemistry.2024; 67(23): 20740. CrossRef
Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles Fadwa M Arafa, Doaa Hassan Osman, Mona Mohamed Tolba, Nadjet Rezki, Mohamed R Aouad, Mohamed Hagar, Mervat Osman, Heba Said Parasitology Research.2023; 122(10): 2353. CrossRef
Synthesis and evaluation of
in vitro
and
in vivo
anti
-Toxoplasma gondii
activity of tetraoxane-substituted ursolic acid derivatives
Ya-Lan Wang, Li-Li Jin, Xu Cheng, Wei-Feng Yan, Hao Deng, Qing-Kun Shen, Zhe-Shan Quan, Chun-Mei Jin, Chang-Hao Zhang Natural Product Research.2023; 37(21): 3654. CrossRef
Pharmacological overview of hederagenin and its derivatives Xing Huang, Qing-Kun Shen, Hong-Yan Guo, Xiaoting Li, Zhe-Shan Quan RSC Medicinal Chemistry.2023; 14(10): 1858. CrossRef
Synthesis and Antitumor Activity of Hederagenin Derivatives Xing Huang, Changhao Zhang, Hao Deng, Qingkun Shen, Hongyan Guo, Zheshan Quan, Zhiyong Li, Lili Jin Chinese Journal of Organic Chemistry.2022; 42(9): 2877. CrossRef
First
Prev
